budesonide/formoterol (Symbicort)

DRUG6 trials

Sponsors

AstraZeneca

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseMild or Moderate Asthma

Phase 3

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

CompletedNCT00421122

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2006-09-30End: 2007-11-30Updated: 2009-03-27

Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

CompletedNCT00646321

AstraZenecaAsthma

Start: 2003-04-30End: 2004-08-31Target: 540Updated: 2011-01-24

Atlantis Symbicort

CompletedNCT00646594

AstraZenecaAsthma

Start: 2003-11-30End: 2005-01-31Target: 1200Updated: 2009-03-27

Long-Term Safety of Symbicort in Asthmatic Children - SAPLING

CompletedNCT00646529

AstraZenecaAsthma

Start: 2002-07-31End: 2003-10-31Target: 175Updated: 2009-03-30

Symbicort Onset of Action 1

CompletedNCT00646620

AstraZenecaAsthma

Start: 2003-04-30End: 2003-09-30Updated: 2009-04-06

Gemini Symbicort pMDI

CompletedNCT00646516

AstraZenecaMild or Moderate Asthma

Start: 2003-10-31End: 2005-02-28Target: 615Updated: 2011-01-24

Related Papers

Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.

2010-08-1611 citations